Showing 606 news articles about New & experimental HIV treatments

Filters Content type: News Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

New & experimental HIV treatments

HIV attachment inhibitor BMS-663068 safe and effective in phase 2b study

News
4 March 2015
HIV treatment

Tenofovir alafenamide equally effective but safer for kidneys and bones than current formulation

News
27 February 2015
New & experimental HIV treatments

HIV maturation inhibitor BMS-955176 looks promising in early study

News
26 February 2015
New & experimental HIV treatments

Once-daily dolutegravir superior to darunavir/ritonavir in 96-week follow-up

News
10 November 2014
New & experimental HIV treatments

Doravirine works as well as efavirenz with fewer CNS side-effects

News
10 November 2014
Injectable & long-acting PrEP

Injectable cabotegravir makes progress towards human efficacy studies: doubts about injectable rilpivirine

News
30 October 2014
The search for a cure

Novel techniques probed in cure research

News
22 July 2014
New & experimental HIV treatments

Therapy with newer, safer antiretrovirals an option for the majority of HIV-positive patients

News
11 July 2014
New & experimental HIV treatments

Investigational protease inhibitor TMC310911 highly potent in phase 2 study

News
4 May 2014
HIV treatment

New NNRTI doravirine matches efavirenz for first-line HIV treatment

News
11 March 2014
New & experimental HIV treatments

Novel two-drug maintenance combination works at least as well as triple therapy: stage set for long-lasting injectable formulation

News
8 March 2014
New & experimental HIV treatments

Protected T-cells persist and proliferate in HIV gene therapy study

News
7 March 2014
The search for a cure

The 'Boston patients' experience HIV rebound after stem cell transplants

News
7 March 2014
New & experimental HIV treatments

HIV attachment inhibitor BMS-663068 shows good safety and efficacy in phase 2b study

News
6 March 2014
Injectable & long-acting PrEP

Monkey studies confirm viability of injectable PrEP drug

News
5 March 2014
Starting treatment

Short course of ART during primary HIV infection has immunological and virological benefits after treatment is stopped

News
27 December 2013
The search for a cure

Progress towards an HIV cure

News
25 November 2013
New & experimental HIV treatments

Once-daily raltegravir effective as maintenance therapy

News
31 October 2013
New & experimental HIV treatments

Dolutegravir matches or surpasses other regimens for first-line HIV treatment

News
30 October 2013
New & experimental HIV treatments

Future HIV care will include both novel antiretroviral drugs and new treatment strategies

News
22 October 2013
New & experimental HIV treatments

GSK1265744 rapidly suppresses HIV and appears safe at selected dose

News
20 October 2013
New & experimental HIV treatments

CCR5 inhibitor cenicriviroc shows good activity against HIV; new formulation may reduce dropouts

News
18 October 2013
Injectable & long-acting HIV treatment

Long-acting antiretrovirals may improve survival for people with poor adherence

News
4 October 2013
PrEP science

New integrase inhibitor GSK1265744 safe and well tolerated in eight studies

News
4 October 2013